Washington – The Food and Drug Authority’s advisory committee still has to decide the future of Pfizer’s RSV vaccine for infants in the US. It is given to pregnant mothers, and if approved, it will become the first RSV vaccine to be administered to infants, which according to the experts is a “big deal.”